Thus, drugs that inhibit or block CCL2-induced cognitive impairment could treat the cognitive dysfunction of HAND patients or improve their learning and memory, which show good prospects for clinical application. The gene discussed is CCL2; the disease is HIV-associated neurocognitive disorder.